Literature DB >> 1748531

Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN).

G Sakellariou1, P Koukoudis, J Karpouzas, E Alexopoulos, D Papadopoulou, F Chrisomalis, N Skenteris, D Tsakaris, M Papadimitriou.   

Abstract

Toxic epidermal necrolysis (TEN) or Lyell's syndrome is a rare fulminating skin disease notorious for its rapidly progressive course and high mortality rate. TEN is characterized by the sudden onset of epithelial necrosis of skin with frequently associated involvement of the gastrointestinal, genitourinary tract and bronchopulmonary linings. We describe the clinical course of five patients with severe drug-induced TEN, treated with PE. The suspected drugs were carbamazepine in one patient, paracetamol in one, a combination of paracetamol and mefenamic acid in one, allopurinol in one and ciprofloxacin in one. Three had a skin involvement affecting almost the entire surface of the body. In addition to the skin lesions, mouth, esophagus and lungs were also involved. Steroids proved ineffective. PE was carried out because of the rapid deterioration of the clinical picture. The mean number of PE sessions was 3.22 (range 1-5). Complete remission of the syndrome was achieved in four patients. One patient died due to septic shock. As so far there is no treatment of proven value for this condition, controlled trials should be set up in order to assess the value of PE in TEN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748531

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  8 in total

1.  60-year-old man with rash.

Authors:  Devin E Shahverdian; Constantinos P Anastassiades; Joseph C Charles
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  Successful Treatment of Stevens-Johnson Syndrome with Cyclosporine and Corticosteroid.

Authors:  Jessica Auyeung; Monica Lee
Journal:  Can J Hosp Pharm       Date:  2018-08-28

Review 3.  Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions.

Authors:  Shih-Chi Su; Wen-Hung Chung
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

Review 4.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

Review 5.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

Review 6.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors:  Jeremy A Schneider; Philip R Cohen
Journal:  Adv Ther       Date:  2017-04-24       Impact factor: 3.845

Review 7.  Interventions for toxic epidermal necrolysis.

Authors:  S Majumdar; M Mockenhaupt; J- Roujeau; A Townshend
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 8.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.